VOYA INVESTMENT MANAGEMENT LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1068837 ATLANTA, GA

Position in APGE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,135,505

-$1,253,071 QoQ

Shares Held

8,555

-69.9% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#179

of 285 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. APGE ranks #80 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
4	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
5	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
6	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
7	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376
8	REGN	Regeneron Pharmaceuticals, Inc.	65,505	$40,844,986

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,135,505	8,555	-69.9%	Shares	Defined	2026-08-12
2026-03-31	$2,388,576	28,378	+53.5%	Shares	Defined	2026-05-12
2025-12-31	$1,395,775	18,492	+97.3%	Shares	Defined	2026-02-12
2025-09-30	$372,428	9,374	-24.7%	Shares	Defined	2025-10-09
2025-06-30	$540,485	12,445	-41.9%	Shares	Defined	2025-08-14
2025-03-31	$800,512	21,427	-53.4%	Shares	Defined	2025-06-18
2024-12-31	$2,081,988	45,960	-18.7%	Shares	Defined	2025-05-02
2024-09-30	$3,319,807	56,517	+121.1%	Shares	Defined	2025-02-07
2024-06-30	$1,005,786	25,560	+91.7%	Shares	Defined	2025-02-07
2024-03-31	$885,977	13,333	+63.5%	Shares	Defined	2025-02-07
2023-12-31	$227,794	8,153	—	Shares	Defined	2025-02-07
No filing history on record for this holder in this stock.